Search Within

Michael Morris

Formats
  1. Meeting Abstract (275)
  2. Journal Article (268)
  3. Review (20)
  4. Book Section (6)
  5. Editorial (6)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Miscellaneous (2)
  9. Conference Paper (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (586)
  2. Genitourinary Oncology Service (586)
  3. Solid Tumor Oncology Division (586)
  4. Radiology, Department of (164)
  5. GSK Faculty (161)
  6. Molecular Imaging and Therapy Service (141)

More Groups

People
  1. Howard Scher (217)
  2. Steven Larson (93)
  3. Susan Slovin (90)
  4. Dana Rathkopf (79)
  5. Daniel Danila (54)
  6. Glenn Heller (54)

More People

Years
  1. 2025 (27)
  2. 2024 (50)
  3. 2023 (40)
  4. 2022 (50)
  5. 2021 (42)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (240)
  2. Journal of Nuclear Medicine (44)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (30)
  5. Cancer (18)
  6. European Urology (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (250)
  2. Society of Nuclear Medicine (44)
  3. American Association for Cancer Research (43)
  4. Oxford University Press (41)
  5. Elsevier Science, Inc. (40)
  6. Elsevier Inc. (27)

More Publishers

Results (586)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)
    Journal Article

    Tilburt, J. C.; Zahrieh, D.; Pacyna, J. E.; Petereit, D. G.; Kaur, J. S.; Rapkin, B. D.; Grubb, R. L.; Chang, G. J. 3rd; Morris, M. J.; Kovac, E. Z.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Real-world use of bone-modifying agents in metastatic castration-sensitive prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Bach, P. B.; Morris, M. J.
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Analytical performance of aPROMISE: Automated anatomic contextualization, detection, and quantification of [(18)F]DCFPyL (PSMA) imaging for standardized reporting
    Journal Article

    Johnsson, K.; Brynolfsson, J.; Sahlstedt, H.; Nickols, N. G.; Rettig, M.; Probst, S.; Morris, M. J.; Bjartell, A.; Eiber, M.; Anand, A.
    European Journal of Nuclear Medicine and Molecular Imaging (2022)

    Fulltext@MSK | Save
  • Correlation between imaging-based intermediate endpoints and overall survival in men with metastatic castration-resistant prostate cancer: Analysis of 28 randomized trials using the Prostate Cancer Clinical Trials Working Group (PCWG2) criteria in 16,511 patients
    Journal Article

    Woo, S.; Suh, C. H.; Wibmer, A. G.; Becker, A. S.; Teo, M. Y.; Gönen, M.; Hricak, H.; Scher, H. I.; Morris, M. J.; Vargas, H. A.
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Appropriate use criteria for prostate-specific membrane antigen PET imaging
    Review

    Jadvar, H.; Calais, J.; Fanti, S.; Feng, F.; Greene, K. L.; Gulley, J. L.; Hofman, M.; Koontz, B. F.; Lin, D. W.; Morris, M. J.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase 3 study of (177)Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)
    Meeting Abstract

    Krause, B.; de Bono, J.; Chi, K. N.; Fizazi, K.; Herrmann, K.; Rahbar, K.; Tagawa, S. T.; Nordquist, L. T.; Vaishampayan, N.; El-Haddad, G.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • A phase 3 study of (18)F-DCFPyL-PET/CT in patients with biochemically recurrent prostate cancer (CONDOR): An analysis of disease detection rate and positive predictive value (PPV) by anatomic region
    Meeting Abstract

    Rowe, S.; Gorin, M.; Saperstein, L.; Pouliot, F.; Josephson, D.; Carroll, P.; Wong, J.; Pantel, A.; Piert, M.; Gage, K.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Lutetium-177 - PSMA-617 for prostate cancer - The authors reply
    Correspondence

    Sartor, O.; Morris, M. J.; Kraus, B. J.
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save